Triglide and Flexeril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triglide (fenofibrate) and Flexeril (cyclobenzaprine hydrochloride). Common drug interactions include glucose tolerance impaired among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Triglide and Flexeril. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Triglide?

Triglide has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 287 Triglide users. Check the latest studies of Triglide.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.



On Jul, 28, 2026

21 people who take Triglide and Flexeril together, and have interactions are studied.

Triglide and Flexeril drug interactions.

What are the common drug interactions of Triglide and Flexeril, by gender? *:

female:

  1. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  2. Histrionic personality disorder (long-standing pattern of attention seeking behaviour and extreme emotionality)
  3. Hyperaesthesia
  4. Dyspepsia (indigestion)
  5. Hepatic steatosis (fatty liver disease)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Coronary artery stenosis (narrowing of coronary artery)
  9. Facial pain
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Pulmonary haemorrhage (acute bleeding from the lung)
  4. Urinary tract infection
  5. Chronic kidney disease
  6. Depression
  7. Emotional distress
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Anaemia (lack of blood)

What are the common drug interactions of Triglide and Flexeril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypokalaemia (low potassium)
  2. Urinary tract infection
  3. Chordoma (a brain tumour from the embryo)
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

40-49:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Multi-organ failure (multisystem organ failure)
  3. Activities of daily living impaired
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Oedema (fluid collection in tissue)
  6. Quality of life decreased
  7. Renal failure (kidney dysfunction)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)

50-59:

  1. Dyspepsia (indigestion)
  2. Hepatic steatosis (fatty liver disease)
  3. Chest discomfort
  4. Costochondritis (chest wall pain)
  5. Depression
  6. Headache (pain in head)
  7. Hypertension (high blood pressure)
  8. Multiple injuries
  9. Neuralgia (pain in one or more nerves)
  10. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)

60+:

n/a

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 9.52%
  2. Pain: 2 people, 9.52%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.52%
  4. Hiv Infection: 2 people, 9.52%
  5. Headache (pain in head): 2 people, 9.52%
  6. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Triglide and Flexeril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triglide and Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triglide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triglide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate and cyclobenzaprine hydrochloride (the active ingredients of Triglide and Flexeril, respectively), and Triglide and Flexeril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: